跳至主要内容
临床试验/JPRN-UMIN000011595
JPRN-UMIN000011595招募中2 期

Phase II Study of combination chemotherapy with SPT in patient with HER2(+) advanced gastric cancer - KGCG-01

Kawasaki Gastric Cancer Group(KGCG)0 个研究点目标入组 15 人开始时间: 2013年8月28日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with a history of serious drug hypersensitivity 2) Patients who are received administration of flucytosine 3) Patients who are received continuous administration of phenytoin, or warfarin. 4) Patients with active infection 5) Patients with serious complication 6) Patients with diarrhea (4 or more times per day or watery diarrhea) 7) Patients with massive ascites or massive pleural effusion retention. 8) Patients with serious heart disease 9) Uncontrolled hypertension 10) Second primary malignancy 11) Women in pregnancy, at risk of pregnancy, hoping to become pregnant 12) Men who want their partners to become pregnant 13) Any patients judged by the investigator to be unfit to participate in the study

研究者

发起方
Kawasaki Gastric Cancer Group(KGCG)

相似试验